{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:39:21Z","timestamp":1790095161609,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.adro.2021.100713","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T01:32:20Z","timestamp":1620523940000},"page":"100713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-2532","authenticated-orcid":false,"given":"Mark F.","family":"McLaughlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Folkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquibul","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Garant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Hudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-3427","authenticated-orcid":false,"given":"Neil B.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2021.100713_bib0001","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2021.100713_bib0002","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0003","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100713_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG Oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0006","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11 Pt B","key":"10.1016\/j.adro.2021.100713_bib0007","first-page":"E647","article-title":"Application technique: Placement of a prostate-rectum spacer in men undergoing prostate radiation therapy","volume":"110","author":"Hatiboglu","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2021.100713_bib0008","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.urology.2013.07.014","article-title":"Learning curve in the application of a hydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer","volume":"82","author":"Pinkawa","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.adro.2021.100713_bib0009","first-page":"9288","article-title":"How I do it: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy","volume":"25","author":"Montoya","year":"2018","journal-title":"Can J Urol"},{"key":"10.1016\/j.adro.2021.100713_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2016.02.014","article-title":"Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial","volume":"59","author":"Hannan","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2021.100713_bib0011","doi-asserted-by":"crossref","unstructured":"Chen L, Gao A, Bhavani S, et\u00a0al. Safety and outcome of stereotactic body radiation therapy (SBRT) with rectal hydrogel spacer for prostate cancer. J Clin Oncol. 38 (Suppl_76).","DOI":"10.1200\/JCO.2020.38.6_suppl.76"},{"key":"10.1016\/j.adro.2021.100713_bib0012","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2010.31.4377","article-title":"Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer","volume":"29","author":"Boike","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0013","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ijrobp.2017.09.020","article-title":"Multi-institutional phase 2 trial of high-dose stereotactic body radiation therapy with temporary hydrogel spacer for low- and intermediate-risk prostate cancer","volume":"99","author":"Folkert","year":"2017","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.adro.2021.100713_bib0014","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/modpathol.3880179","article-title":"Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues","volume":"13","author":"Kumar","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.adro.2021.100713_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fonc.2014.00319","article-title":"Stereotactic body radiation therapy for prostate cancer: Review of experience of a multicenter phase I\/II dose-escalation study","volume":"4","author":"Kim","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0016","first-page":"40","article-title":"The natural history of radiation-induced proctosigmoiditis: An analysis of 88 patients","volume":"52","author":"Gilinsky","year":"1983","journal-title":"Q J Med"},{"key":"10.1016\/j.adro.2021.100713_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(96)00468-3","article-title":"Late GI and GU complications in the treatment of prostate cancer","volume":"37","author":"Schultheiss","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100713_bib0018","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","article-title":"Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall","volume":"7","author":"Fischer-Valuck","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0019","unstructured":"National Comprehensive Cancer Network. Bone Cancer (Version 2.2021). Available at:http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf. Accessed February 17, 2021."},{"key":"10.1016\/j.adro.2021.100713_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2021.100713_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100713_bib0022","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0023","unstructured":"Administration USFaD. MAUDE: Manufacturer and user facility device experience. Secondary MAUDE: Manufacturer and user facility device experience April 30, 2020. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm. Accessed April 30, 2020."},{"key":"10.1016\/j.adro.2021.100713_bib0024","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/end.2019.0431","article-title":"Major complications and adverse events related to the injection of the spaceoar hydrogel system before radiotherapy for prostate cancer: Review of the manufacturer and user facility device experience database","volume":"33","author":"Aminsharifi","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.adro.2021.100713_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206931","article-title":"Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy","volume":"2014","author":"Teh","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.adro.2021.100713_bib0026","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/UPJ.0000000000000071","article-title":"A case of rectal ulcer during intensity modulated radiotherapy for prostate cancer using hydrogel spacer","volume":"7","author":"Dinh Tru-Khang","year":"2020","journal-title":"Urology Practice"},{"key":"10.1016\/j.adro.2021.100713_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13014-019-1248-6","article-title":"Rectum-spacer related acute toxicity: Endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers","volume":"14","author":"Sch\u00f6rghofer","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2021.100713_bib0028","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.24223","article-title":"Late rectal complications after prostate brachytherapy for localized prostate cancer: Incidence and management","volume":"115","author":"Phan","year":"2009","journal-title":"Cancer"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:39:15Z","timestamp":1762529955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109421000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2452109421000713"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2021.100713","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2021.100713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100713"}}